hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants
Cell Discov
.
2021 Jul 20;7(1):54.
doi: 10.1038/s41421-021-00293-y.
Authors
Junli Liu
#
1
,
Qi Chen
#
2
,
Shumin Yang
1
,
Ying Li
1
,
Yang Dou
3
,
Yong-Qiang Deng
2
,
Jinpeng Bi
4
,
Yongcong Tan
5
,
Hongfan Wang
1
,
Wei Gong
1
,
Xiaoyu Xu
4
,
Zhenhu Li
1
,
Guojun Lang
5
,
Cheng-Feng Qin
2
,
Bai Lu
6
7
,
Weidong Jiang
8
Affiliations
1
Shanghai Henlius Biotech, Inc., Shanghai, China.
2
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, China.
3
School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing, China.
4
Vazyme Biotech Co., Ltd., Nanjing, China.
5
Sanyou Biopharmaceuticals Co., Ltd., Shanghai, China.
6
School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing, China. bai_lu@tsinghua.edu.cn.
7
Beijing Tiantan Hospital, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China. bai_lu@tsinghua.edu.cn.
8
Shanghai Henlius Biotech, Inc., Shanghai, China. donjiang_99@yahoo.com.
#
Contributed equally.
PMID:
34285198
PMCID:
PMC8290864
DOI:
10.1038/s41421-021-00293-y
No abstract available
Publication types
Letter